POLR2H and hepatocellular carcinoma: We found that the expression of JUN (P=0.037) was related to worse overall survival (OS) for HCC patients, as well as IL8 (called as CXCL8) (P=0.011), VEGFA (P=0.014), EHHADH (P=0.026), FUS (P=0.04), HSPA1A (P=0.048), CUL1 (P=0.022), and POLR2H (P=0.0012).